Zdeněk Andrysík
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 4
- Oncology top 5%
- Cancer-related Molecular Pathways 12
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 9
- RNA modifications and cancer 6
- Connexins and lens biology 3
- Cell death mechanisms and regulation 3
- Heme Oxygenase-1 and Carbon Monoxide 3
- Ubiquitin and proteasome pathways 3
- Biotechnology top 10%
- Co-authors
- Joaquı́n M. EspinosaMatthew D. GalbraithKelly D. SullivanAnna L. GuarnieriAhwan PandeyMaria HohAlois Kozubı́kRobin D. Dowell
- Partner nations
- United StatesCzechiaItaly
In The Last Decade
Zdeněk Andrysík
26 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 378
- Oncology 513
- Molecular Biology 1.0k
- Biotechnology 60
- Cell Biology 96
Countries citing papers authored by Zdeněk Andrysík
This map shows the geographic impact of Zdeněk Andrysík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdeněk Andrysík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdeněk Andrysík more than expected).
Fields of papers citing papers by Zdeněk Andrysík
This network shows the impact of papers produced by Zdeněk Andrysík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdeněk Andrysík. The network helps show where Zdeněk Andrysík may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zdeněk Andrysík, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 14 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 18 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 39 | |
| 6 | 2020 | 10 | |
| 7 | 2020 | 21 | |
| 8 | 2018 | 34 | |
| 9 | 2018 | 51 | |
| 10 | 2018 | 168 | |
| 11 | 2017 | 108 | |
| 12 | 2017 | 63 | |
| 13 | 2017 | 333 | |
| 14 | 2013 | 58 | |
| 15 | 2012 | 30 | |
| 16 | 2008 | 20 | |
| 17 | 2006 | 37 | |
| 18 | 2005 | 22 | |
| 19 | 2005 | 23 | |
| 20 | 2002 | 11 |
About Zdeněk Andrysík
Zdeněk Andrysík is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 26 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (12 papers), Epigenetics and DNA Methylation (9 papers), RNA modifications and cancer (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), Connexins and lens biology (3 papers), Cell death mechanisms and regulation (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (378 citations), Oncology (513 citations) and Molecular Biology (1.0k citations). Zdeněk Andrysík has collaborated with scholars based in United States, Czechia and Italy. Frequent co-authors include Joaquı́n M. Espinosa, Matthew D. Galbraith, Kelly D. Sullivan, Anna L. Guarnieri, Ahwan Pandey, Maria Hoh, Alois Kozubı́k, Robin D. Dowell, Michael P. Ludwig and Christina G. Towers. Their work appears in journals such as Nature Communications, The EMBO Journal and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.